Posted by AGORACOM-JC
at 6:53 PM on Thursday, January 21st, 2021
Today’s press release from HPQ might have been a little technical for newcomers but the words from CEO Bernard Tourillon explain exactly how important it was:
“With the Gen1 PUREVAP TM NSiR operational and exceeding expectations from the start, HPQ NANO is uniquely positioned to be at the forefront of low-cost manufacturing of Nano Silicon for batteries and other applications ….. We are very confident that the Silicon materials we are producing, with our expected low-cost scalable processes, will be in high demand by batteries, EV manufacturers and other participants in the ongoing renewable energy revolution.”
Moreover, Tourillon couldn’t help but display his feelings and proclaimed this was going to be a fun year for HPQ.
Posted by AGORACOM-JC
at 9:38 AM on Thursday, January 21st, 2021
Q3 2020 Financial Highlights:
Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019.
A combined $3.12 Million raised through private placement subscriptions with strategic investors.
January 21, 2021 – Toronto – Binovi Technologies Corp. (Binovi) (TSXV:VISN ) I ( OTC:BNVIF ) | ( GR:2EYA ) a leader in neuro-vision performance technology, reports results for the Company’s fiscal third quarter, ended November 30, 2020. The Company’s net sales results continue to be affected by the global health crisis. Increased demand for products across multiple categories led to an increase in top-line and gross margin results.
“Strategically positioned within telehealth, we believe the coming quarters will be pivotal in establishing our reputation and status as a competitor within this rapidly growing marketplace. While we are seeing strong growth across the business, it is important to recognize that we are making big investments in our people and infrastructure that are essential to support the significant growth that lies ahead. This includes big investments in our telehealth SaaS, our provider network, and personnel are critical as we scale the business,” stated Executive Chairman, Terry Booth.
Q3 2020 Financial Highlights:
Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019.
A combined $3.12 Million raised through private placement subscriptions with strategic investors.
Operational Highlights:
Since the launch of Binovi, more than 800 organizations have been registered and have used the platform for vision therapy and/or sports vision performance. These organizations have created nearly 31,000 users, together completing more than 400,000 active sessions centered around the Binovi Library list of activities, custom activities created by our member organizations.
Advanced the development of the company’s web-based telehealth SaaS, Binovi Connect. The beta launch of the platform is planned for Q1 2021.
Product marketing continues to grow brand awareness and promote sales, with an increase of 300% in website traffic, with improvements in direct media marketing and general top-of-mind awareness.
Posted by AGORACOM
at 9:28 AM on Thursday, January 21st, 2021
Acquired never before published exploration data from 1957 to 1965
This effectively triples the overburden drilling data that will give Beauce unprecedented overview of the placer channel
Beauce Gold Fields (TSXV: BGF) (Champs D’Or en Beauce),(“BGF”), is pleased to announce that it has acquired, from a Private Collector, a trove of never before published exploration data by the Beauce Placer Mining company that operated from 1957 to 1965 on the company’s Beauce Gold property located in Saint-Simon-les-Mines, Quebec.
Patrick Levasseur, President and CEO of Beauce Gold Fields said, “This effectively triples the overburden drilling data that will give us an unprecedented overview of the placer channel.” Mr. Levasseur added: “The data will have a profound impact in orientating our future rock drilling program to uncover the source of the gold placers.”
Active from 1957 to 1965, the Beauce Placer Company was the largest placer gold mining operation in eastern North America. Yet, there was very little documentation available of the work completed during that period. Historical reports found on the Government of Quebec’s geology and mining data registry are but brief summaries and observations. Missing were drill hole logs and subsequent results, geophysics data, field surveys, compilation maps and for that matter, all aspects pertaining to the dredge mining operation itself. These have now been found.
According to the Collector, the documents originated from a field office the Beauce Placer Mining Company occupied in Beauceville, Quebec. The office was abandoned in the 1970s leaving behind filing cabinets full of documents. The documents were given to the Collector, a businessman from St-Simon-les-Mine. Being an avid antiques collector, he recognized the importance of preserving historical documentation pertaining to his town’s heritage.
Document Highlights
– Total 344 drill logs from 7-inch wide overburden drill holes down to bedrock:
Gilbert River (St-Simon-les-Mine) – 252 holes
Famine River – 40 holes
Chaudière River – 36 holes
Riviere Du Loup – 12 holes
Ruisseau Des Meule – 4 holes
– Geophysics – Claims and property agreements – Land surveys – Documentation regarding the operation of the dragline and the Yuba dredge – Daily back office operation – Gold receipts from the mint
Posted by AGORACOM-JC
at 8:07 AM on Thursday, January 21st, 2021
Updated and amended its collaboration with Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, and initiated prioritized pre-clinical studies on the RHO Phyto formulations that are commercialized in Canada and Colombia.
Additionally, the Company provides an update on research projects with the University of Toronto and Thompson Rivers University as well as a change to its management team.
TORONTO, Jan. 21, 2021– Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products has updated and amended its collaboration with Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, and initiated prioritized pre-clinical studies on the RHO Phyto formulations that are commercialized in Canada and Colombia. Additionally, the Company provides an update on research projects with the University of Toronto and Thompson Rivers University as well as a change to its management team.
Initiation of pre-clinical studies on RHO Phyto in collaboration with University of Guelph
Further to Avicanna’s previous announcement regarding Dr. Khokhar’s research team at the University of Guelph being awarded a Natural Sciences and Engineering Research Council of Canada (“ NSERC ”) Alliance grant focused on the neurobiological underpinnings of cannabis toxicosis with the aim to evaluate Avicanna’s formulations in the treatment of cannabis-induced toxicosis, the project is now being expanded. The expansion of the project includes pharmacokinetic and behavioural testing of Avicanna’s RHO Phyto™ formulations as well as studying their efficacy in alleviating neuropathic pain and addiction. The data generated from the research will help guide Avicanna’s clinical development, including the pharmaceutical and real-world evidence studies related to the RHO Phyto formulations, and will provide additional information to health care practitioners who are recommending and prescribing the products in several markets.
COVID-19 drug candidate project update
The research collaboration with the University of Toronto on the development of a drug candidate to treat lung inflammation caused by COVID-19, with funding support from an NSERC Alliance grant and a MITACS Alliance grant, is complete. The peer-reviewed grants were focused on the development of a cannabinoid formulation to be used for further research on COVID-19. The physical and chemical characterization of the optimized cannabinoid formulation is complete, which included its stability and drug release properties in relevant conditions.
COVID-19 and anti-inflammatory related research collaboration with TRU with non-dilutive funding
In partnership with Avicanna, Dr. Kingsley Donkor and collaborators from Thompson Rivers University (” TRU ”), will be evaluating naturally derived cannabinoids and candidate formulations for their efficacy to modulate the receiving receptor of COVID-19 (angiotensin-converting ACE2 gene expression). This project will focus on elucidating the mechanism of action of novel prophylactic nasal and oral cannabinoid products for humans that target ACE2 viral gateways. Candidate formulations, once identified, will be evaluated for anti-inflammatory effects in human-derived lung tissue models. The research with TRU is supported by an NSERC grant and a MITACS Internship.
Posted by AGORACOM
at 2:07 PM on Wednesday, January 20th, 2021
Mr. Paul Pelosi, Jr. as a Director and the President of St-Georges’ new subsidiary, EVSX Corp
EVSX Corp is dedicated to electric vehicle battery recycling and future partnerships in the development of lithium mineral resources.
St-Georges Eco-Mining Corp. (CSE:SX)(OTC:SXOOF) (CNSX:SX.CN) (FSE:85G1) is pleased to welcome Mr. Paul Pelosi, Jr. as a Director and the President of St-Georges’ new subsidiary, EVSX Corp. which is dedicated to electric vehicle battery recycling and future partnerships in the development of lithium mineral resources.
Paul’s expertise in green technology, eco-responsible investments, and regulatory governmental environmental legislative framework will play a critical role in developing and deploying St-Georges’ lithium mineral processing technology and EV battery recycling technology initiative.
St-Georges and its partner, Altair International, have joined forces to develop metallurgical solutions for the recycling of lithium and other metals from EV batteries. They are working diligently to complete a long-form agreement before the end of the month.
About Paul Pelosi, Jr.
Paul Pelosi Jr. has many years of experience contributing to the sustainability of the environment through his service as President of the Environment Commission in San Francisco. The commission develops policies and programs in recycling, environmental justice, toxic reduction, energy efficiency, climate change, eco-friendly commuting alternatives, and policies regarding preserving the city’s urban forest. Paul’s experience includes emerging company investments, investment banking, sustainable real estate, and corporate governance. In each of these ventures, he was instrumental in developing corporate governance practices that advanced new technologies while supporting all stakeholders.
Paul graduated from Georgetown University with a Bachelor of Arts in History and an MBA with an emphasis in International Business. He holds a juris doctor. He is known for his humanitarian beliefs and work in the field and received the Georgetown International Human Rights Award in 1994. He has been a member of the California State Bar since 1996.
About EVSX Corp.
EVSX Corp. was recently incorporated as a wholly-owned subsidiary of St-Georges Eco-Mining Corp. The Company will use this subsidiary to operate all research and development and hold patents and intellectual property developed within the proposed joint-venture partnership with Altair International.
Altair has the option to acquire 49.99% of the common shares of EVSX by issuing shares to St-Georges and making certain milestones payments (for more details, See Press Release “St-Georges Inks Licensing & Development Agreement for Lithium Processing Technology” dated December 1, 2020)
The Board and Management of EVSX will initially be composed of these individuals:
– Paul Pelosi Jr., Director & President – Mark Billings, Director & CFO – Vilhjalmur Thor Vilhjalmsson, Director – Enrico Di Cesare, Director & CEO.
Vilhjalmur Thor Vilhjalmsson,President and Chief Executive Officer of St-Georges Eco-Mining, commented, “(…) St-Georges is excited to be expanding our commitment to the environment to the recycling of lithium car batteries. Paul is the ideal candidate to be heading up this venture. He has a proven track record in promoting green technologies, which marries well with St-Georges’ core values and our deep concern for the ecosystem. We look forward to working with Paul on this and will continue to develop cutting-edge eco-green technologies for other ventures. (…)’
Posted in All Recent Posts | Comments Off on St.George Eco Mining $SX.ca $SXOOF Appoints Paul Pelosi, Jr. Becomes President of St-Georges’ Subsidiary $NNX.ca $OM.ca $ICM.ca
Posted by AGORACOM
at 9:39 AM on Wednesday, January 20th, 2021
Upsized its previously announced brokered private placement for gross proceeds of approximately C$27 million
Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, is pleased to announce that it has upsized its previously announced brokered private placement of units (the “Units”) of the Company at a price of C$2.55 per SVS Unit (as defined below) for gross proceeds of approximately C$27 million (the “Offering”), representing an increase of C$7 million, due to excess demand. ATB Capital Markets and Beacon Securities Limited are co-lead agents to the Offering (the “Agents”).
The Company has granted the Agents an option to sell up to an additional 15% of the Units in the Offering, exercisable in whole or in part at any time prior to closing of the Offering.
As previously announced, Entourage Effect Capital, LLC, one of the largest shareholders of Harborside, is participating in the Offering with approximately C$9.0 million in commitment.
Posted by AGORACOM
at 8:51 AM on Wednesday, January 20th, 2021
Karl brings to the Board his unique experiences in building and operating some of the most profitable graphite mines in the Western World.
Gratomic Inc. (“GRAT” or the “Company”) (TSX.V:GRAT)(OTCQB:CBULF)(FRANKFURT:CB82)(WKN:A143MR) announces the appointment of Karl Trudeau as a Director of the Company and Head of Namibian Operations.
Karl brings to the Board his unique experiences in building and operating some of the most profitable graphite mines in the Western World. Working for Imerys Graphite et Carbonne, he operated and optimized the Lac-Des-Îles graphite mine to become the most profitable mining operation in Quebec in 2014. An additional significant milestone was achieved with Imerys, through his role as Natural Graphite Operations Leader, where Karl was responsible for the construction and development of the Okanjande Graphite Mine in Namibia, Africa.
As the COO of Nouveau Monde Graphite, Karl made important contributions to the project including his work as a pioneer in the electrification of mining operations. As the world is changing, Gratomic will be a focused leader in making the necessary and important change of establishing carbon neutral operations. Karl brings with him the knowledge from previous projects, which will assist in making the Company’s Aukam Graphite Project a carbon neutral operation.
The strength of established working relationships on previous projects with Armando Farhate and Andre Bennet and having a strong track record of delivering to plan will be a key contributing factor to the success of the Aukam Graphite Project.
“I had the privilege of working directly with Karl in other Graphite projects and having him side by side at the Board of Directors of Gratomic will ensure we continue to improve our governance level,” said Armando Farhate, COO & Head of Graphite Marketing and Sales.
“On behalf of the Board of Directors, I am very pleased to welcome Karl to the Board. This step solidifies his role with the Company and represents a harbinger of the success to come in Gratomic’s future,” said Arno Brand, President & CEO of Gratomic Inc.
The appointment of Karl Trudeau as a director is subject to the approval of the TSX Venture Exchange.
Posted by AGORACOM
at 6:35 PM on Tuesday, January 19th, 2021
2020 Preliminary Results and 2021 Outlook also provided
Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, today announced a brokered private placement of units (the “Units”) of the Company (the “Offering”) at a price of C$2.55 per SVS Unit (as defined below) for gross proceeds of approximately C$20 million with approximately C$9.0 million of commitment from Entourage Effect Capital, LLC (“Entourage”), one of the largest shareholders of Harborside.
The Company has granted the Agents (as defined below) an option to sell up to an additional 15% of the Units in the Offering, exercisable in whole or in part at any time prior to closing of the Offering.
Each Unit issued to non-residents of the United States (an “SVS Unit”) will be comprised of one subordinate voting share of the Company (the “Subordinate Voting Shares”) and one Subordinate Voting Share purchase warrant (each a “Warrant”) of the Company. Each Warrant will be exercisable to acquire one Subordinate Voting Share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering (the “Closing Date”) at an exercise price of C$3.69 per Warrant Share, subject to adjustment and acceleration in certain events.
All investors that are considered residents of the United States under the United States Securities Exchange Act of 1934, will be issued units comprised of multiple voting shares of the Company (the “Multiple Voting Shares”) and Multiple Voting Share purchase warrants of the Company, which will be based on the same economic equivalency of each Multiple Voting Share converting into 100 Subordinate Voting Shares.
“We are continuing to expand our footprint in the robust California cannabis market, delivering our best-in-class service and the high-quality product selection that Harborside is known for,” said Matthew Hawkins, Chairman of Harborside. “California is one of the largest cannabis markets in the world and Harborside has more than a decade of market success for our team to build on. I would like to thank our current and new shareholders for their overwhelming support of our growth strategy. This additional capital will solidify our balance sheet and provide a platform for us to continue to consolidate in the California market through accretive M&A transactions.”
Posted by AGORACOM-JC
at 5:57 PM on Tuesday, January 19th, 2021
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
This model has resulted in the following success:
$5.3M in revenues in the first 9 months of 2020 (ending July 31, 2020)
9 products currently in the market with an annual estimated peak sales of $40M/year
7 products in the pipeline with an annual estimated peak sales of $45M/year
In fact, capital markets confidence is so high that Valeo secured $8.6M in financing in the last half of the year with:
$6.9M Bought Deal financing at $1.20/shares
A $1.7M Oversubscribed debenture (non-convertible)
If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.
But then came Redesca. We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH. The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-30% of this market. If you’re doing back of napkin math, that equates to $30,000,000 – $60,000,000 per year in revenues.
But how does a new product capture that much market share? Glad you asked because we asked CEO Steve Saviuk the same question. Competition is tough in all markets and they don’t let someone take 15-30% market share without one hell of a fight.
Saviuk agreed and gave the following reasons:
1. Redesca has an 8-year international track record of safety and efficacy. It is already well known
2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.
Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”
Well there you have it. Valeo is a great story. Watch the video.
HOLD ON. THERE’S MORE … A LOT MORE
In a recently issued newsletter by MDBriefCase entitled “Exploring Novel Therapeutic Approaches for Covid-19: Hesperidin vs Vitamin C” the newsletter stated that recently accumulated evidence suggests that Hesperidin supplementation may be useful as a prophylactic agent against SARS-Cov-2 infection and as a complementary treatment during COVID-19 disease. What does this mean?
Growing body of research suggests Hesperidin may interfere with SARS-CoV-2 infection process
Hesperidin may help against Covid-19 viral replication
Hesperidin is a potent antioxidant with anti-inflammatory activity that may help in controlling cytokine storm (where the body starts to attack its own cells and tissue rather than just the virus)
Valeo’s unique Hesperidin formulation (HESPERCO) is the only format available where every capsule contains 500mg of concentrated Hesperidin.
Now you have it. That’s the Valeo story as it applies to just 2 of their amazing products. There is a whole lot more to the story given their pipeline of products but we couldn’t cover it all in this great interview with CEO Steve Saviuk.
If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.
